The majority of human rhinoviruses use intercellular adhesion molecule 1 (ICAM-1) as a cell surface receptor. Two soluble forms of ICAM-1, one corresponding to the entire extracellular portion [tICAM(453)] and one corresponding to the two N-terminal immunoglobulin-like domains [tICAM(185) The majority of human rhinoviruses, the major causative agent of the common cold, utilize intercellular adhesion molecule 1 (ICAM-1) as a receptor on host cells (11). ICAM-1 is an integral membrane protein with a large N-terminal extracellular portion, a transmembrane anchor, and a short C-terminal cytoplasmic domain. The normal physiological function of ICAM-1 is to serve as a membrane-bound ligand of the leukocyte integrin lymphocyte function-associated antigen 1 (LFA-1) and mediate intercellular adhesion between leukocytes and a variety of cell types (17, 18, 33). The protein has sequence homology with members of the immunoglobulin supergene family, and its extracellular domain can be divided into five immunoglobulin-like domains (32, 35) . Electron microscopy (34) has indicated that ICAM-1 is a highly elongated molecule.
The majority of human rhinoviruses, the major causative agent of the common cold, utilize intercellular adhesion molecule 1 (ICAM-1) as a receptor on host cells (11) . ICAM-1 is an integral membrane protein with a large N-terminal extracellular portion, a transmembrane anchor, and a short C-terminal cytoplasmic domain. The normal physiological function of ICAM-1 is to serve as a membrane-bound ligand of the leukocyte integrin lymphocyte function-associated antigen 1 (LFA-1) and mediate intercellular adhesion between leukocytes and a variety of cell types (17, 18, 33) . The protein has sequence homology with members of the immunoglobulin supergene family, and its extracellular domain can be divided into five immunoglobulin-like domains (32, 35) . Electron microscopy (34) has indicated that ICAM-1 is a highly elongated molecule.
The 3-dimensional structure of two rhinovirus serotypes have now been determined to atomic resolution by Rossmann and colleagues (15, 25) . The virion is composed of a protein capsid of 60 protomeric units, consisting of the four protein subunits (VP1 to VP4), surrounding an RNA genome. Each of the 60 protomeric units possesses a recessed canyon that is likely to contain the receptor binding site (for a review, see reference 24) . The dimensions of the canyon are such that it is too small to admit the combining site of an antibody but is apparently large enough to admit the virus binding site of ICAM-1. The precise extent of the virus binding site on ICAM-1 remains to be determined, although results from mouse-human chimeras and site-directed muta- genesis indicate that the N-terminal domain plays a major role in virus binding (20, 34) , and a molecular model has been developed for the interaction of the N-terminal domain of ICAM-1 with the rhinovirus canyon (9) . Detergent-solubilized transmembrane ICAM-1 binds to rhinovirus in solution (11) , and a truncated form of ICAM-1 consisting of the extracellular domain binds to and neutralizes rhinovirus (19) .
In an effort to further understand the molecular basis of * Corresponding author.
rhinovirus-ICAM-1 interaction and to determine the mechanism by which soluble ICAM-1 neutralizes rhinovirus, we have produced two truncated soluble forms of ICAM-1. In this report, the properties of these proteins are described and their abilities to inhibit rhinovirus-receptor binding and infectivity are compared. These data indicate that there are three distinct mechanisms by which soluble ICAM-1 prevents virus infection and have implications for the role of the receptor in virus uncoating within host cells.
MATERIALS AND METHODS
cDNA constructions. Modified forms of the ICAM-1 cDNA were created by polymerase chain reaction (29) by using the full-length ICAM-1 cDNA pHRR-2 (11) as template. Plasmid DNA was digested with EcoRl to excise the ICAM-1 insert and treated with alkaline phosphatase to prevent recircularization of the vector in subsequent ligation steps. Template DNA (10 ng) was subjected to 10 cycles of polymerase chain reaction amplification with the 5' oligonucleotide primer GGAATTCAAGCTTCTCAGCCTCGCTATGGCTCCCAG CAGCCCCCGGCCC Protein purification. ICAM-1 was prepared from detergent lysates of HEl cells, and tICAM(453) and tICAM(185) were purified from culture supernatants of their respective CHO transfectant cell lines by monoclonal antibody affinity chromatography as described previously (11) and then by either ion-exchange chromatography on Mono-Q for tICAM (453) with absorption in 10 mM Tris (pH 6.0) and elution with a 0 to 0.5 M NaCl gradient or gel filtration on Superose-12 columns (Pharmacia) for tICAM (185 (21) , and the pellets were resuspended in 0.1 ml of 1% SDS. RNase-free glycogen (Boehringer Mannheim) was added as a carrier to a concentration of 200 ,ug/ml, and RNA was extracted essentially as described by Rueckert and Pallansch (27) from equal amounts of [35S]methionine radioactivity (2,500 cpm, or approximately 10 ng of HRV3). Samples were applied to Gene Screen Plus filters (NEN) in dot blot apparatus as described previously (31) . Filters were then prehybridized with 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-5x Denhardt's solution-0.5% SDS-0.2 mg of salmon sperm DNA per ml for 1 h at 37°C and then hybridized with a -32P-labeled oligonucleotide probe for nucleotides 455 to 471 of the positive (+) strand of HRV14 (5'-GCATTCAGGGGCCGGAG-3'; final concentration of 2 ng/ml) for 18 h at 37°C. The blot was washed with 2 x SSC-1% SDS twice at 20°C and twice at 42°C before autoradiography.
RESULTS
Expression of soluble truncated forms of ICAM-1. ICAM-1 cDNAs encoding soluble proteins were constructed by inserting stop codons within the reading frame of the ICAM-1 polypeptide. Thus, stop codons were inserted immediately before the first residue of the transmembrane domain, at the predicted ends of domains 1, 2, and 3, domains 1 and 2, and domain 1 to produce a series of progressively truncated proteins (Fig. 1A) . The cDNAs were cloned into the expression vector CDM8, transfected into COS cells for transient expression, and cotransfected with pSV2-dihydrofolate reductase into CHO cells for establishment of stable cell lines. In the experiment for which the results are shown in Fig. 1B , the secretion of various forms of truncated ICAM-1 in transiently transfected COS cells was examined. The results indicated that the entire extracellular domain, tICAM(453), and the two N-terminal domains, tICAM(185), were efficiently secreted from transfected COS cells as species of 80,000 Da and 43,000 Da, respectively (Fig. 1B) (283) was not obtained, perhaps because the low level of secretion was at the limit of sensitivity of the immunoassay. The cells were adapted to serum-free media, and the secreted ICAM-1 proteins were purified to homogeneity from culture supernatants (Fig. 1C) calculated frictional coefficients), was 1.9 for both tICAM (453) and tICAM(185), indicating that both fragments of ICAM-1 are highly asymmetric and elongated molecules. CD spectra were obtained for the soluble forms of ICAM-1. A single minimum at 210 to 220 nm is indicative of the presence of ,B structure and should be seen in proteins containing immunoglobulin-like domains because of the extensive amount of P structure in the immunoglobulin fold (38) . As internal standards, spectra were collected for two members of the immunoglobulin supergene family of known 3-dimensional structure, ,-2-microglobulin (4) and a murine monoclonal IgG (1). As expected, the spectra of P-2-microglobulin (not shown) and IgG ( Fig. 2A) possessed single minima at 215 nm and 217 nm, respectively. The spectra of the two truncated proteins, tICAM(453) and tICAM(185), were similar to each other and to that of ICAM-1 (Fig. 2B, C, and D) , with minima at 216 to 217 nm and a broad shoulder at 225 to 230 nm, although the shoulder was more pronounced in tICAM(185) than in tICAM(453). These CD spectra provide additional evidence that the soluble ICAM-1 proteins are properly folded and that they possess significant amounts of ,B structure. Fig. 4 were obtained.
at concentrations of 3.1 + 1.8 ,uM (n = 3) and 9.7 + 3.2 ,uM (n = 3), respectively, inhibit the binding of 35S-HRV3 by 50%.
Inhibition of virus infectivity by soluble ICAM-1. The effect of soluble ICAM-1 on rhinovirus infectivity was examined under several different conditions ( Fig. 3B and C Fig. 3B ), and the mixture was then diluted to negligible ICAM-1 concentrations for infection of HeLa cells. The titers of tICAM(453)-and tICAM(185)-treated virus were 1.9 x 105 PFU/ml and 3.0 x 105 PFU/ml, respectively, compared with 3.6 x 105 PFU/ml for control virus (Table 1 , experiment III). Only marginal reduction of virus titer (<50%) was observed at 20 ,uM soluble ICAM-1, indicating that the ICAM-1-mediated neutralization of rhinovirus is largely reversible; this reversibility is presumably due to simple dissociation of the virus-receptor complex upon dilution.
Thus, the neutralizing activity of tICAM(185) is directly correlated with its ability to inhibit virus-receptor binding, while tICAM(453) neutralizes rhinovirus at a concentration considerably lower than that necessary to inhibit binding and is presumably acting by a mechanism in addition to direct competition for receptor-binding sites on the virus. Neutralization of rhinovirus by both forms of ICAM-1 is largely reversible.
Effect of soluble ICAM-1 on rhinovirus integrity. Samples of 35S-HRV3 incubated with tICAM(453) and tICAM (185) under conditions similar to those in the binding and infectivity experiments were analyzed by sedimentation through sucrose gradients. HRV3 incubated with 10 ,uM tICAM(453) separated into three peaks, 149S (cosedimenting with native virus), 135S, and 80S (Fig. 4A) PFU/cpm ratio of 15; the residual infectivity is probably due to slight contamination from the 149S and 135S peaks since the gradients were fractionated from the bottom. This 80S species was also generated upon incubation with tICAM(185), although less efficiently (Fig. 4B) . The fraction of HRV3 in the 80S peak in the sample treated with 10 FM tICAM(453) was 18% after 30 min and 61% after 24 h. The rate of conversion to the 80S species is highly temperature dependent and is greater at 37°C than at 34°C, the optimal temperature for rhinovirus growth (10) . Since this concentration of tICAM(453) reduced infectivity to <0.2% (Fig. 3B ) and since the reduction of infectivity is largely reversible, the conversion of rhinovirus to the noninfectious 80S species does not play a major role in rhinovirus neutralization by soluble ICAM-1.
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The 149S, 135S, and 80S peaks were characterized with respect to their viral capsid composition and RNA content. Analysis of peak fractions by SDS-PAGE revealed that the 149S and 135S peaks possessed all four capsid proteins, while the 80S peak had dramatically reduced amounts of VP4 (Fig. 5) . To assess the RNA content of the three peaks, preparations of [35S]methionine-and [3H]uridine-labeled HRV3 incubated with 10 ,uM tICAM(453) were separated on sucrose gradients (Fig. 6) . The radioactivity from the [35S]methionine-labeled virus formed a clear 80S peak, which was insensitive to RNase A. The radioactivity from the [3H]uridine-labeled virus formed 149S and 135S peaks but no 80S peak. When RNase A was included in the incubation, the 149S and 135S peaks were not altered, while the remainder of the radioactivity distributed across the top half of the gradient shifted to the top of the gradient. These data indicate that the 80S peak does not contain RNA and that the 149S, 135S, and 80S peaks are insensitive to RNase A digestion. In a second experiment, the viral RNA content was determined directly by extraction of RNA from equal amounts of radioactivity from 149S, 135S, and 80S peaks of [35S]methionine-labeled HRV3 and then by dot blot analysis with an oligonucleotide probe for the positive (+) strand of rhinovirus (Fig. 7) . This experiment showed that the 149S and 135S peaks but not the 80S peak contained viral RNA. Thus, the 80S peak appears to be an empty capsid, lacking both RNA and VP4. The 135S peak contains both VP4 and RNA and is infectious. Although the nature of the 135S peak is unclear at present, it is likely that it is a virion with altered hydrodynamic properties due to interaction with ICAM-1.
DISCUSSION
In this report, we have described the production and characterization of two soluble forms of ICAM-1, the major human rhinovirus receptor, and their effects on virus-receptor binding, virus infectivity, and virus integrity. The results from these experiments allow us to distinguish three distinct mechanisms by which soluble ICAM-1 blocks virus growth and to identify the regions of ICAM-1 responsible for these activities. In addition, the results presented show that receptor protein can uncoat the rhinovirus particle in vitro and, thus, have implications for the mechanism of virus uncoating in vivo.
ICAM-1 has a domain structure that is related to the immunoglobulin supergene family, and its extracellular portion can be divided into five immunoglobulin-like domains (32, 35 (2) . A likely explanation for these findings is that an intimate interaction exists between certain domains, particularly between domains 1 and 2, which is required for proper folding or solubility of the polypeptide; the close packing between domains 1 and 2 of CD4 revealed by its crystal structure has provided evidence in favor of this interpretation (28, 37) . Physical characterization of tICAM (453) (5) , while significant, is not high (data not shown). Domain 1,  in particular, has a number of unusual features for an immunoglobulin-like domain, such as a relatively short distance (44 residues) between intradomain disulfide bonds and four instead of two cysteines in the B and F P strands. Thus, structural predictions based on the immunoglobulin fold motif should be made with caution.
Competitive binding studies indicate that the binding site for rhinovirus is largely contained within the first two domains. This conclusion is consistent with studies on transmembrane ICAM-1, in that human-mouse chimera studies by Staunton et al. (34) poliovirus and other picornaviruses generated during infection of cells (7, 8, 13) , which are thought to be products of the uncoating process (26) . It has been demonstrated that poliovirus can be conformationally altered in cell-free systems by membranes containing poliovirus receptor (6, 12) or detergent-solubilized poliovirus receptor (14) to a 135S form lacking VP4 but still containing RNA (in an RNase-sensitive state). However, release of RNA requires further treatment of the 135S species with high concentrations of salt (14) or SDS (6, 12) , and generation of 80S empty capsids requires live cells (8) . We have demonstrated here that truncated soluble ICAM-1 can alter rhinovirus to an 80S species lacking both VP4 and RNA and, thus, essentially uncoats the virus. We have also identified an intermediate 135S particle which results from ICAM-1-rhinovirus interaction; this particle differs from the 135S poliovirus altered particle in that it is infectious and contains VP4. These differences between rhinovirus and poliovirus with respect to the products of in vitro virus-receptor interaction may reflect differences in the rate-limiting steps for' uncoating between rhinovirus and poliovirus or may reflect the different experimental conditions under which the experiments were performed. The alteration of rhinovirus by soluble ICAM-1 clearly indicates that receptor can completely uncoat rhinovirus in the absence of other cellular components, suggesting that destabilization of the rhinovirus by receptor plays a role in the uncoating process in vivo. This may be a general phenomenon, as it has recently been reported that soluble CD4 induces the release of gpl20 from the human immunodeficiency virus virion, and it has been hypothesized that this release of gpl20 from virions attached to'the cell surface may expose regions of gp4l molecules that could promote fusion of the virion and cell membranes (22, 23) , which occurs at neutral pH at the cell surface (36) . However, the physiological significance of ICAM-1-mediated uncoating in vivo is unclear since there is also a requirement for a chloroquinesensitive low-pH step inside the cell for rhinovirus infection (10) . A more detailed description of the in vitro alteration of rhinovirus by ICAM-1 and its role in virus uncoating in vivo will be presented elsewhere. However, it is clear from the data presented here that uncoating does not play a major role in soluble ICAM-1-mediated neutralization of rhinovirus under the conditions of optimal rhinovirus growth, since the inhibitory activity of soluble ICAM-1 toward virus infection is largely reversible and because the conversion to the 80S form can only account for a small fraction of this activity.
In conclusion, we have demonstrated that two forms of soluble ICAM-1, tICAM(453) and tICAM(185), inhibit virusreceptor binding and virus infectivity. Differential effects of these two proteins on these processes have defined three distinct mechanisms of virus neutralization. The first mechanism appears to be a simple competition of soluble receptor for receptor binding sites on the virus, and determinants within domains 1 and 2 of ICAM-1 are responsible for this activity. The second mechanism is a reversible neutralization in which virus is apparently blocked at an entry or uncoating step and involves contributions from domains 3, 4, and 5. The third mechanism is an irreversible inactivation of the virus characterized by the loss of the virus subunit VP4 and the RNA genome.
